Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.485, 2005-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etanercept dominates therapy options for RA in Mexico
Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. :
Access to resources
Recommend
Early etanercept worth it in RA therapy sequence
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. :
Tocilizumab dominates adalimumab for severe RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Etanercept: beneficial effects in early RA
Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. :